102 related articles for article (PubMed ID: 24631395)
1. Peripheral administration of poly I:C leads to increased hippocampal amyloid-beta and cognitive deficits in a non-transgenic mouse.
Weintraub MK; Kranjac D; Eimerbrink MJ; Pearson SJ; Vinson BT; Patel J; Summers WM; Parnell TB; Boehm GW; Chumley MJ
Behav Brain Res; 2014 Jun; 266():183-7. PubMed ID: 24631395
[TBL] [Abstract][Full Text] [Related]
2. Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse.
Kahn MS; Kranjac D; Alonzo CA; Haase JH; Cedillos RO; McLinden KA; Boehm GW; Chumley MJ
Behav Brain Res; 2012 Apr; 229(1):176-84. PubMed ID: 22249135
[TBL] [Abstract][Full Text] [Related]
3. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
4. Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure.
Weintraub MK; Bisson CM; Nouri JN; Vinson BT; Eimerbrink MJ; Kranjac D; Boehm GW; Chumley MJ
Brain Behav Immun; 2013 Oct; 33():24-8. PubMed ID: 23665252
[TBL] [Abstract][Full Text] [Related]
5. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I:C administration.
White JD; Eimerbrink MJ; Hayes HB; Hardy A; Van Enkevort EA; Peterman JL; Chumley MJ; Boehm GW
Behav Brain Res; 2016 Oct; 313():219-225. PubMed ID: 27449203
[TBL] [Abstract][Full Text] [Related]
7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
8. The α5-GABA
Eimerbrink MJ; Pendry RJ; Hodges SL; Wiles JD; Peterman JL; White JD; Hayes HB; Chumley MJ; Boehm GW
Behav Brain Res; 2019 Feb; 359():871-877. PubMed ID: 30031883
[TBL] [Abstract][Full Text] [Related]
9. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
14. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
15. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
Fabbro S; Schaller K; Seeds NW
J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
